Non Small Cell Lung Cancer Market Size And Share

  • Report Code : TIPRE00026054
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

2025-2031年非小细胞肺癌市场规模、份额及预测

Buy Now

Non-small Cell Lung Cancer Market Report Non-small Cell Lung Cancer Market Scope and Analysis Non-small Cell Lung Cancer Market Size and Share

Non-small Cell Lung Cancer Market Report Analysis

Non-small Cell Lung Cancer Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Eli Lilly And Company
  • AstraZeneca
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • ONO PHARMACEUTICAL CO., LTD.
  • Boehringer Ingelheim International GmbH

Regional Overview

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲

Market Segmentation

By 癌症类型
  • 腺癌
  • 鳞状细胞癌
  • 大细胞癌
By 治疗
  • 贝伐单抗
  • 达拉非尼/曲美替尼
  • 盐酸厄洛替尼
  • 奥希替尼等
By 分销渠道
  • 医院药房
  • 零售药房
  • 网上药房等
By 地理
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲